Ensocell is a Life Science company utilising cutting-edge single cell genomics technologies, AI-based computational tools, and advanced cell models to identify novel disease intervention points and to discover novel therapeutics for autoimmune, inflammatory, and fibrotic diseases. Founded by leading scientists at Sanger Institute, the company is located at the Wellcome Trust Genome Campus in Hinxton, UK, and in San Francisco, USA.
Company Details
- Employees
- 19
- Founded
- 2023
- Address
- Biodata Innovation Centre, Wellcome Genome Campus
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.ensocell.com/
- Keywords
- Single Cell Genomics, AI-based Computational Tools, Cell Models, Inflammatory Diseases, Autoimmune Diseases, Fibrotic Diseases.
- HQ
- Cambridge
Ensocell Questions
Ensocell's website is http://www.ensocell.com/
Ensocell's LinkedIn profile is https://www.linkedin.com/company/ensocell-therapeutics-ltd
Ensocell has
19 employees.
View email and phone details for 19
employees at Ensocell.
Ensocell's industry is
Biotechnology Research
Ensocell's top competitors are
Insmed Incorporated,
Nxera Pharma,
Alchemab Therapeutics Ltd,
Eyebio,
Amber Therapeutics,
Rxbiologics,
Prima Mente,
Maxion Therapeutics,
Astoriom,
Centillion.
Ensocell's categories are Biotechnology Research
Ensocell's founding year is 2023
